Genitourinary Syndrome of Menopause: Current Treatment Options in Breast Cancer Survivors – Systematic Review

The overall survival of women with breast cancer (BC) has increased over the last decades, despite the increasing prevalence of this disease. This improved survival is largely due to advances in the current therapies, especially since the introduction of anti-HER2 targeted drugs [1]. Many breast cancer survivors (BCS) are still of premenopausal age and have the potential risk of receiving antineoplastic treatments that may affect ovarian function or anti-oestrogenic treatments that mimic a postmenopausal state [2].
Source: Maturitas - Category: Primary Care Authors: Tags: Review Source Type: research